Table 7.
CARE Case studies
| Morton, 201293 | ||
|---|---|---|
| 1. | Title | 1 |
| 2. | Key Words | 1 |
| 3. | Abstract | |
| a. | Introduction | 1 |
| b. | Patient’s main concerns and important clinical findings. | 1 |
| c. | The main diagnoses, intervention and outcomes. | 1 |
| d. | Conclusion – what are the “take away” lessons? | 1 |
| 4 | Introduction | 1 |
| 5 | Patient information | |
| a. | De-identified demographic and other patient information. | 1 |
| b. | Main concerns of the symptoms of the patient. | 1 |
| c. | Medical, family and psychosocial history including genetic information. | 1 |
| d. | Relevant past interventions and their outcomes. | 0 |
| 6. | Clinical findings | 0 |
| 7. | Timeline | 0 |
| 8. | Diagnostic Assessment | |
| a. | Diagnostic methods (PE, laboratory testing, imaging, surveys) | 0 |
| b. | Diagnostic challenges | N/A |
| c. | Diagnostic reasoning including differential diagnosis | N/A |
| d. | Prognostic characteristics when applicable | N/A |
| 9. | Therapeutic Intervention | |
| a. | Types of intervention (pharmacologic, surgical, preventive) | 0 |
| b. | Administration of intervention (dosage, strength, duration) | 0 |
| c. | Changes in the intervention with explanations | N/A |
| 10. | Follow up and Outcomes | |
| a. | Clinician and patient-assessed outcomes when appropriate. | 0 |
| b. | Important follow-up diagnostic and other test results. | 1 |
| c. | Intervention adherence and tolerability (how was this assessed). | N/A |
| d. | Adverse and unanticipated events. | 1 |
| 11 | Discussion | |
| a. | Strengths and limitations in your approach to the case. | 0 |
| b. | Discussion of the relevant medical literature. | 1 |
| c. | The rationale for your conclusion. | 1 |
| d. | Primary “take-away” lessons from this case report. | 1 |
| 12 | Patient perspective | 0 |
| 13. | Informed consent | 1 |
| Total | 16 | |
| Adverse events Reported | Yes |